Le remplacement de la tyrosine par la phknylalanine dans l'oxytocine, c'est-Pdire la suppression de l'hydroxyle phCnolique de cette hormone, conduit P la Ph& oxytocine (dksoxy-oxytocine), dont la synthhse a 6th rCalisCe indkpendamment par notre groupe1)2) et par celui de DU VIGNEAUD~). Lorsque cett
Synthèse de la Lys8-oxytocine (lysine-vasotocine) et nouvelle synthèse de la lysine-vasopressine
✍ Scribed by R. A. Boissonnas; R. L. Huguenin
- Publisher
- John Wiley and Sons
- Year
- 1960
- Tongue
- German
- Weight
- 620 KB
- Volume
- 43
- Category
- Article
- ISSN
- 0018-019X
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
N‐CBO‐L‐Glutaminyl‐L‐asparaginyl‐S‐benzyl‐L‐cysteinyl‐azide has been condensed with L‐prolyl‐ϵ‐N‐tosyl‐L‐lysyl‐glycinamide, giving N‐CBO‐L‐glutaminyl L‐asparaginyl‐S‐benzyl‐L‐cysteinyl‐L‐prolylϵ‐N‐tosyl‐L‐lysyl‐glycinamide, which after spliting of the CBO‐protecting group has been condensed with N‐CBO‐S‐benzyl‐L‐cysteinyl‐L‐tyrosyl‐L‐isoleucyl‐azide. Cleavage of the protecting groups of the resulting nonapeptide with sodium in liquid ammonia, oxidation with air in dilute aqueous solution and purification by counter‐current distribution afforded Lys^8^‐oxytocin, which represents a structural intermediate between oxytocin and lysine‐vasopressin and which exhibits the biological properties of both these natural hormones.
📜 SIMILAR VOLUMES
S-CRO-L-Pyroglutanzyl-L-se'r~?il-NE-CBO-L-lys~nate de me'thyle . On dissont 1.,72 g (4,s mmoles) de L-sCryl-NE-CBO-L-lysinatc de mCthyle (11-33) clans un melange de 20 nil de chlorurc dc methylhe et 20 ml d'acktate d'dthyle contenant 1,85 g (4,8 mmoles) de N-CBO-Lpyroglutamatc de p -n i t r o p h d
## Abstract An improved synthesis of Bradykinin is described. N‐CBO‐G‐tosyl‐L‐arginyl‐L‐prolyl‐L‐prolyl‐glycine __p__‐nitrophenyl ester and L‐phenylalanyl‐L‐seryl‐L‐prolyl‐L‐phenylalanyl‐G‐tosyl‐L‐arginine are prepared and condensed together to N‐CBO‐G‐tosyl‐L‐arginyl‐L‐prolyl‐L‐prolyl‐glycyl‐L‐phe
To 1 2 3 4 5 6 7 8 9 AbrCviations: CBO-= carbobenzoxy-; Tos-= p-toluknesulfonyl-= tosyl-; Bz-= benzyl: -NP = P-nitrophknyle; -CP = trichloro-2,4,5-phCnyle. Gly8-oxytocine. La Buts-oxytocine est encore plus active que les deux prkckdents analogues. I1 est intkressant de constater que la Glys-oxytoc
TIELVETICA CHIMICA ACTA ting of the CBO-protecting group ha; been condensed with N-CBO-S-benzyl-I<cysteinyl-L-tyrosyl-L-isoleucyl-azide. Cleavage of the protecting groups of the resulting nonapeptide with sodium in liquid ammonia, oxidation with air in dilute aqueous solution and purification by cou
Ul'IM~\ R'I' Rac. 2-dehydro-emetine (XV) and rac. 2-dehydro-isoemetine (XVI) have been synthcsizcd in fivc steps and in good yicld from 2-oxo-3-ethyl-9,10-dimethoxy-l, 2,3, 4,6, . Homologues and analogues of XV and XVI with other substituents have been obtained in the same way. Rac. 2-dchydro-emeti